US FDA clears Pfizer Covid-19 booster for older and at-risk Americans
The panel voted against the proposition that boosters were needed by everyone but said evidence showed they were helpful to older people and those at high risk
The panel voted against the proposition that boosters were needed by everyone but said evidence showed they were helpful to older people and those at high risk